Intarcia Therapeutics, Inc
Pharmaceutical company · Hayward, California, United States
Intarcia Therapeutics, Inc is a pharmaceutical company headquartered in Hayward, California, United States. It has reported private securities offerings to the US SEC, most recently $198 million sold in a notice filed in 2020.
Profile compiled from public records. Is this your company? Request a correction or update
Intarcia Therapeutics at a glance
Typepharmaceutical company
HeadquartersHayward, California, United States
SEC industryPharmaceutical Preparations
SEC CIK1086688
What does Intarcia Therapeutics do?
Private fundraising reported to the SEC
19 Form D notices; the most recent reported $198.5 million sold (2020).
Frequently asked questions about Intarcia Therapeutics
Where is Intarcia Therapeutics headquartered?
Intarcia Therapeutics, Inc is headquartered in Hayward, California, United States.
What does Intarcia Therapeutics do?
Intarcia Therapeutics, Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Benitec Biopharma Inc.Hayward, California, United States
- Anthera Pharmaceuticals IncHayward, California, United States
- Arcus Biosciences, Inc.Hayward, California, United States
- Impax Laboratories, LLCHayward, California, United States
- Aarvik Therapeutics, Inc.Hayward, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences